COPD Exacerbation by SARS-CoV-2. A Cause of Future Poor Disease Control?

COPD Exacerbation by SARS-CoV-2. A Cause of Future Poor Disease Control?

Saved in:

Bibliographic Details
Main Authors:	Juan Marco Figueira-Gonçalves, Rafael Golpe
Format:	Article
Language:	English
Published:	Elsevier 2024-10-01
Series:	Open Respiratory Archives
Online Access:	http://www.sciencedirect.com/science/article/pii/S2659663624000912
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Current Evidence on the Usefulness of Potential Therapies in the Prevention of COPD Exacerbations: Beyond the Use of Bronchodilator Therapy and Inhaled Corticosteroids
by: Juan Marco Figueira-Gonçalves, et al.
Published: (2025-04-01)

SARS-CoV-2 pandemic and beyond: The impact of the SARS-CoV-2 pandemic on Turkish youth and their attitude toward future prospects
by: Lale Turkmen, et al.
Published: (2023-07-01)

Is unilateral facial palsy truly caused by SARS-CoV-2?
by: Josef Finsterer, et al.
Published: (2021-03-01)

Can SARS-CoV-2 Be a Potential Cause of Microcephaly?
by: Gonca Keskindemirci, et al.
Published: (2024-12-01)

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2.
by: Kwang Su Kim, et al.
Published: (2021-03-01)

TNF-α exacerbates SARS-CoV-2 infection by stimulating CXCL1 production from macrophages.
by: Moe Kobayashi, et al.
Published: (2024-12-01)

Acute necrotizing encephalopathy caused by SARS-CoV-2 in a child
by: Po-Yuan Wang, et al.
Published: (2022-11-01)

Main Pharmacological Strategies Against SARS-CoV-2
by: Thais Gonçalves Fontes, et al.
Published: (2020-09-01)

Acute Exacerbation of Cold Agglutinin Disease by SARS-CoV-2 Infection: A Rural U.S. Hospital Experience
by: Jackson Musuuza, et al.
Published: (2024-01-01)

Natural disasters and SARS-CoV-2: potential risk factors for exacerbating mental health conditions among veterans
by: Parthasarathy Arpitha, et al.
Published: (2025-03-01)

Management of Children with Disease Caused by New Coronaviral Infection (SARS-CoV-2)
by: Yurii S. Alexandrovich, et al.
Published: (2020-06-01)

Detection of Bacterial causes of diarrhea in patients with SARS-CoV-2 in Samarraa city
by: Noor Asaad Ahmed, et al.
Published: (2022-11-01)

Reply to “Vaccination caused underestimation of cumulative incidence of SARS-CoV-2 infection”
by: Jefferson M. Jones, et al.
Published: (2025-02-01)

Molecular Epidemiology of SARS-CoV-2 in Bangladesh
by: Abu Sayeed Mohammad Mahmud, et al.
Published: (2025-04-01)

The Intersection of SARS-CoV-2 and Diabetes
by: Jacob H. Nichols, et al.
Published: (2025-06-01)

In-silico Immunomodelling of SARS-CoV-2
by: Amirhosein Maali, et al.
Published: (2021-06-01)

SARS-CoV-2 associated encephalitis
by: Jasmina Poluga, et al.
Published: (2025-05-01)

Stability of SARS-CoV-2 phylogenies.
by: Yatish Turakhia, et al.
Published: (2020-11-01)

Susceptibility of rabbits to SARS-CoV-2
by: Anna Z. Mykytyn, et al.
Published: (2021-01-01)

SARS-CoV-2-Neutralizing Antibodies
by: Yawen Liu, et al.
Published: (2024-11-01)

Low Exhaled Breath Droplet Formation May Explain Why Children are Poor SARS-CoV-2 Transmitters
by: Michael Riediker, et al.
Published: (2020-06-01)

Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses.
by: Felicitas Ruiz, et al.
Published: (2024-10-01)

SARS-CoV-2 Alchemy: Understanding the dynamics of age, vaccination, and geography in the evolution of SARS-CoV-2 in India.
by: Mansi Patel, et al.
Published: (2025-03-01)

Risk factors and effectiveness of vaccination for nosocomial SARS-CoV-2 acquisition throughout the SARS-CoV-2 pandemic
by: Nishi Dave, et al.
Published: (2025-08-01)

Evaluation of the MAScIR SARS-CoV-2 M Kit 2.0 on the SARS-CoV-2 Infection
by: Amal Zouaki, et al.
Published: (2023-01-01)

Impaired Hemorheology in Exacerbations of COPD
by: Erhan Ugurlu, et al.
Published: (2017-01-01)

In silico exploration of binding potentials of anti SARS-CoV-1 phytochemicals against main protease of SARS-CoV-2
by: Abdullah G. Al-Sehemi, et al.
Published: (2022-05-01)

Co-infection associated with SARS-CoV-2 and their management
by: Vivek P Chavda, et al.
Published: (2022-10-01)

An investigation into male infertility caused by hormonal imbalance and hypertension brought on by SARS-CoV-2
by: Parameswari R, et al.
Published: (2025-07-01)

The SARS-CoV-2 main protease causes mitochondrial dysfunction in a yeast model
by: Wojciech Grabiński, et al.
Published: (2025-07-01)

Clinical manifestations of asthenic syndrome after coronavirus infection caused by SARS-CoV-2
by: A. O. Mikhailov, et al.
Published: (2023-07-01)

Pneumothorax in a patient with pneumonia caused by SARS-CoV-2: A case report
by: Novković Ljiljana, et al.
Published: (2021-01-01)

Forecasting the Effects of the New SARS-CoV-2 Variant in Europe
by: Iván Area, et al.
Published: (2021-01-01)

Respiratory infections cause the release of extracellular vesicles: implications in exacerbation of asthma/COPD.
by: Suffwan Eltom, et al.
Published: (2014-01-01)

Bronchopleural fistula spontaneous closure after SARS-CoV-2 infection
by: Ana Sara Gonçalves, et al.
Published: (2025-06-01)

SARS-CoV-2 Spike Protein Vaccine-Induced Immune Imprinting Reduces Nucleocapsid Protein Antibody Response in SARS-CoV-2 Infection
by: Juan F. Delgado, et al.
Published: (2022-01-01)

SARS-CoV-2 Detection From Voice
by: Gadi Pinkas, et al.
Published: (2020-01-01)

Racing for a SARS‐CoV‐2 vaccine
by: Özlem Türeci, et al.
Published: (2021-09-01)

Clinical Traits of SARS-CoV-2 Infection
by: O. Yu. Zolnikova, et al.
Published: (2020-12-01)

Monitoring and assessment of SARS-CoV-2 evolution
by: V. V. Miasoiedov, et al.
Published: (2022-02-01)